Albemarle Stock 5-Day Winning Spree: Stock Climbs 26%

ALB: Albemarle logo
ALB
Albemarle

Albemarle (ALB) stock hit day 5 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 26% return. The company has gained about $2.7 Bil in value over the last 5 days, with its current market capitalization at about $13 Bil. The stock remains 35.5% above its value at the end of 2024. This compares with year-to-date returns of 14.6% for the S&P 500.

Albemarle’s recent streak was fueled by a robust Q3 earnings beat, signaling a turnaround in profitability. Optimism surged on renewed lithium demand for EVs and energy storage, coupled with strategic asset sales and multiple analyst price target hikes, validating the company’s operational resilience.

What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. Our take: There are several things to fear in ALB stock given its overall Weak operating performance and financial condition. This isn’t appropriately reflected in the stock’s Moderate valuation which is why we think it is Unattractive (see Buy or Sell ALB). Nevertheless, equities is not the only thing we do. Is a portfolio of 10% commodities, 10% gold, and 2% crypto in addition to equities and bonds – likely to return more and protect you better? We have crunched the numbers.

For quick background, ALB provides engineered specialty chemicals across Lithium, Bromine, and Catalysts segments, including lithium compounds, fire safety solutions, chemical synthesis additives, and industrial purification products.

Relevant Articles
  1. Vertiv Stock: Betting on Power and Heat In The AI Era
  2. Micron Stock: Up 170% And Still Cheap?
  3. Why On Earth Is SpaceX Worth $800 Billion?
  4. The Next Big Rally in Ford Motor Stock Could Start Like This
  5. The Risk Factors to Watch Out For in NVIDIA Stock
  6. Intuitive Surgical Stock Now 16% Cheaper, Time To Buy

Comparing ALB Stock Returns With The S&P 500

The following table summarizes the return for ALB stock vs. the S&P 500 index over different periods, including the current streak:
 

Return Period ALB S&P 500
1D 3.9% -1.7%
5D (Current Streak) 25.5% 0.3%
1M (21D) 16.7% 1.0%
3M (63D) 40.2% 4.5%
YTD 2025 35.5% 14.6%
2024 -39.5% 23.3%
2023 -32.8% 24.2%
2022 -6.6% -19.4%

 
However, big gains can follow sharp reversals – but how has ALB behaved after prior drops? See ALB Dip Buyer Analysis to learn more.

Gains and Losses Streaks: S&P 500 Constituents

There are currently 62 S&P constituents with 3 days or more of consecutive gains and 40 constituents with 3 days or more of consecutive losses.
 

Consecutive Days # of Gainers # of Losers
3D 27 28
4D 8 12
5D 15 0
6D 6 0
7D or more 6 0
Total >=3 D 62 40

 
 
Key Financials for Albemarle (ALB)

Last 2 Fiscal Years:

Metric FY2023 FY2024
Revenues $9.6 Bil $5.4 Bil
Operating Income $190.2 Mil $-642.2 Mil
Net Income $1.6 Bil $-1.2 Bil

Last 2 Fiscal Quarters:

Metric 2025 FQ2 2025 FQ3
Revenues $1.3 Bil $1.3 Bil
Operating Income $52.0 Mil $-33.6 Mil
Net Income $22.9 Mil $-160.7 Mil

 
While ALB stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.